You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 165 No. 21, November 28, 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (3)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Complementary and Alternative Medicine
 •Adverse Effects
 •Alert me on articles by topic

Inadvertent Iodine Excess Causing Thyrotoxic Hypokalemic Periodic Paralysis

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The recent interesting article by Ohye et al1 addressed the continuing problem of nonprescribed and occult medication use. I applaud the scientific dedication of the 2 lead authors who took it upon themselves to ingest the implicated tablets, which have been analyzed to contain portions of tetraiodothyronine (T4) and triiodothyronine (T3). Most would have been convinced without the need to take this extra step, which is unnecessary for 2 reasons. The first is that data on the pharmacokinetic of T3 and T4 are well established.2 The 34 µg to 45 µg of T4 would have few biological effects owing to the binding of T4 to circulating proteins. As the half-life of T4 is 7 to 10 days, a good 4 to 6 weeks of consistent T4 ingestion would need to occur to ensure a therapeutic level. The elevated T3 level is consistent with its short half-life, and the . . . [Full Text of this Article]


AUTHOR INFORMATION
Huy A. Tran, MD, FRCPA


RELATED ARTICLES

Inadvertent Iodine Excess Causing Thyrotoxic Hypokalemic Periodic Paralysis—Reply
Hidemi Ohye, Masahiro Sugawara, and Shuji Fukata
Arch Intern Med. 2005;165(21):2536.
EXTRACT | FULL TEXT  

Thyrotoxicosis Caused by Weight-Reducing Herbal Medicines
Hidemi Ohye, Shuji Fukata, Maki Kanoh, Sumihisa Kubota, Kanji Kuma, Akira Miyauchi, and Masahiro Sugawara
Arch Intern Med. 2005;165(8):831-834.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.